Support for a bipolar affective disorder susceptibility locus on chromosome 12q24.3

Psychiatric Genetics

Volumn 20, Issue 3, 2010, Pages 93-101

  Buttenchoøn, Henriette Nørmoølle ^a   Foldager, Leslie ^a,b   Flint, Tracey J ^a   Olsen, Inger Marie L ^a   Deleuran, Thomas ^a   Nyegaard, Mette ^b   Hansen, Mette M ^a   Kallunki, Pekka ^c   Christensen, Kenneth V ^c   Blackwood, Douglas H ^e   Muir, Walter J ^e   Straarup, Steen E ^a   Als, Thomas D ^a   Nordentoft, Merete ^d   Boørglum, Anders D ^a,b   Mors, Ole ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c H LUNDBECK A S   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

12q24.3; Association; Bipolar affective disorder; Schizophrenia; Slynar

Indexed keywords

COMPLEMENTARY DNA; DNA MARKER;

ALLELE; ARTICLE; BIPOLAR DISORDER; CHROMOSOME 12Q; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; UNITED KINGDOM;

ALLELES; BIPOLAR DISORDER; BRAIN; CHROMOSOMES, HUMAN, PAIR 12; DENMARK; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 77953808748     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833a2066     Document Type: Article

References (42)

1. Amaral PP, Mattick JS (2008). Noncoding RNA in development. Mamm Genome 19:454-492.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Association.
3. Atanasoski S, Toldo SS, Malipiero U, Schreiber E, Fries R, Fontana A (1995). Isolation of the human genomic brain-2/N-Oct 3 gene (POUF3) and assignment to chromosome 6q16. Genomics 26:272-280.
4. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, et al. (2008). A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197-207.
5. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR (2003). ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571.
6. Curtis D, Kalsi G, Brynjolfsson J, McInnis M, O'Neill J, Smyth C, et al. (2003). Genome scan of pedigrees multiply affected with bipolar disorder provides further support for the presence of a susceptibility locus on chromosome 12q23-q24, and suggests the presence of additional loci on 1p and 1q. Psychiatr Genet 13:77-84.
7. Degn B, Lundorf MD, Wang A, Vang M, Mors O, Kruse TA, Ewald H (2001). Further evidence for a bipolar risk gene on chromosome 12q24 suggested by investigation of haplotype sharing and allelic association in patients from the Faroe Islands. Mol Psychiatry 6:450-455. (Pubitemid 32566097)
8. Ewald H, Degn B, Mors O, Kruse TA (1998). Significant linkage between bipolar affective disorder and chromosome 12q24. Psychiatr Genet 8:131-140. (Pubitemid 28479008)
9. Ewald H, Flint T, Kruse TA, Mors O (2002). A genome-wide scan shows significant linkage between bipolar disorder and chromosome 12q24.3 and suggestive linkage to chromosomes 1p22-21, 4p16, 6q14-22, 10q26 and 16p13.3. Mol Psychiatry 7:734-744.
10. Fairbrother WG, Yeh RF, Sharp PA, Burge CB (2002). Predictive identification of exonic splicing enhancers in human genes. Science 297:1007-1013.
11. Gaunt TR, Rodriguez S, Zapata C, Day IN (2006). MIDAS: software for analysis and visualisation of interallelic disequilibrium between multiallelic markers. BMC Bioinformatics 7:227.
12. Hommel G (1988). A stagewise rejective multiple test procedure based on a modified Bonferroni test. Biometrika 75:383-386.
13. Jones I, Jacobsen N, Green EK, Elvidge GP, Owen MJ, Craddock N (2002). Evidence for familial cosegregation of major affective disorder and genetic markers flanking the gene for Darier's disease. Mol Psychiatry 7:424-427.
14. Kalsi G, McQuillin A, Degn B, Lundorf MD, Bass NJ, Lawrence J, et al. (2006). Identification of the Slynar gene (AY070435) and related brain expressed sequences as a candidate gene for susceptibility to affective disorders through allelic and haplotypic association with bipolar disorder on chromosome 12q24. Am J Psychiatry 163:1767-1776.
15. Kato T (2007). Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61:3-19.
16. Lewis PO, Zaykin D (2001). Genetic data analysis: computer program for the analysis of allelic data. Version 1.0 (d16c).
17. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408.
18. Long AD, Grote MN, Langley CH (1997). Genetic analysis of complex diseases. Science 275:1328.
19. Lyons-Warren A, Chang JJ, Balkissoon R, Kamiya A, Garant M, Nurnberger J, et al. (2005). Evidence of association between bipolar disorder and Citron on chromosome 12q24. Mol Psychiatry 10:807-809.
20. Morissette J, Villeneuve A, Bordeleau L, Rochette D, Laberge C, Gagne B, et al. (1999). Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24. Am J Med Genet 88:567-587.
21. Quandt K, Frech K, Karas H, Wingender E, Werner T (1995). MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-4884.
22. R Development Core Team (2004). R: a language and environment for Statistical Computing, Vienna, Austria. R Foundation for statistical computing.
23. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, et al. (2006). A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 11:286-300.
24. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002). Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434.
25. Schmittgen TD, Zakrajsek BA, Mills AG, Gorn V, Singer MJ, Reed MW (2000). Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal Biochem 285:194-204.
26. Schreiber E, Tobler A, Malipiero U, Schaffner W, Fontana A (1993). cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif. Nucleic Acids Res 21:253-258.
27. Severinsen JE, Bjarkam CR, Kiaer-Larsen S, Olsen IM, Nielsen MM, Blechingberg J, et al. (2006). Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder. Mol Psychiatry 11:1126-1138.
28. Shaffer JP (1995). Multiple hypothesis testing. Annu Rev Psychol 46:561-584.
29. Shink E, Harvey M, Tremblay M, Gagne B, Belleau P, Raymond C, et al. (2005a). Analysis of microsatellite markers and single nucleotide polymorphisms in candidate genes for susceptibility to bipolar affective disorder in the chromosome 12Q24.31 region. Am J Med Genet B Neuropsychiatr Genet 135B:50-58.
30. Shink E, Morissette J, Sherrington R, Barden N (2005b). A genome-wide scan points to a susceptibility locus for bipolar disorder on chromosome 12. Mol Psychiatry 10:545-552.
31. Shinkai T, Ohmori O, Hori H, Nakamura J (2002). Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia. Mol Psychiatry 7:560-563.
32. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, et al. (2008).Wholegenome association study of bipolar disorder. Mol Psychiatry 13:558-569.
33. Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR (2006). An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum Mol Genet 15:2490-2508.
34. Thierry-Mieg D, Thierry-Mieg J (2006). AceView: a comprehensive cDNA-supported gene and transcripts annotation. Genome Biol 7 (Suppl 1):S12-S14.
35. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, Burge CB (2004). Systematic identification and analysis of exonic splicing silencers. Cell 119:831-845.
36. Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 447:661-678.
37. Werner T (2000). Computer-assisted analysis of transcription control regions. Matinspector and other programs. Methods Mol Biol 132:337-349.
38. Winer J, Jung CK, Shackel I, Williams PM (1999). Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 270:41-49.
39. World Health Organization (1993). The ICD10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research.
40. World Health Organization (1998). Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN.
41. Yeo G, Hoon S, Venkatesh B, Burge CB (2004). Variation in sequence and organization of splicing regulatory elements in vertebrate genes. Proc Natl Acad Sci U S A 101:15700-15705.
42. Zubenko GS, Hughes HB III, Stiffler JS (1999). Neurobiological correlates of a putative risk allele for Alzheimer's disease on chromosome 12q. Neurology 52:725-732